Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas. - Wikidata - awgldk - TriplyDB

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

http://www.wikidata.org/entity/Q41431886

about

Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids The influence of subclonal resistance mutations on targeted cancer therapy Pancreatic cancer: Are "liquid biopsies" ready for prime-time?Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer Clinical applications of liquid biopsies in gastrointestinal oncology Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma.Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9.Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.Genomic and Epigenomic Alterations in Cancer Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.Pancreatic cancer in 2015: Precision medicine in pancreatic cancer--fact or fiction?Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.No association between metformin use and survival in patients with pancreatic cancer: An observational cohort study.Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.Platelets, circulating tumor cells, and the circulome.Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer.Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.Using circulating cell-free DNA to monitor personalized cancer therapy.Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative.Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.Molecular landscape of pancreatic cancer: challenges and clinical implications.Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients.How can next-generation diagnostics aid pancreatic adenocarcinoma treatment?Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer.Prediction of pancreatic cancer risk and therapeutic response with next-generation sequencing.An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters.Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.

P2860

Q26739062-F8246CED-5CB3-49D0-B230-CBA9C206D2FA Q26781693-9F56BDC2-4DD0-411D-968F-D8DCEAFF9210 Q28068665-AB7E2137-299D-4EE2-885B-0A23B883179D Q28069755-87FFA772-6D28-4E79-9C46-7CDF3B323B83 Q28073730-153E7F9E-514B-4FBE-A790-B8332CA5F87F Q28073765-E4277374-BDA0-4D83-B00B-3C9359007FB9 Q33737740-FC303A00-CB2B-440F-891F-690C8E8710D3 Q33803923-56328C0E-2424-43C6-8318-4BD92042CB8B Q35810461-975497CF-5FB1-47B9-9D1B-5D6975ECF795 Q36376138-C4BC3C2C-7416-4E62-B0EA-BCD0ADF1839C Q36437111-6ED96EEE-95D7-4865-8226-B0CD92FA1459 Q36687536-737F5070-E345-464A-AD93-A31EC5976897 Q36716660-467703AD-D0D1-406F-B1DA-5E96FFACB537 Q37057145-E110465B-F114-41D4-9459-1BDFCD2B86FE Q37242412-1C66C870-A224-42D0-8840-7AE3CBF0FD50 Q37641762-65412145-2A8F-4B44-876C-DE310B4B5051 Q37662237-AD4EB3E5-E189-4144-8AA7-862789CD2E48 Q37687088-E3CEE353-E826-4B60-AF9C-11ACD74B4A34 Q38693932-5FF539F1-4433-4178-ADC7-A223E8F46115 Q38726457-48DF6BBA-01B6-4E0E-ADC6-4F92A2A5B19B Q38748916-FED0A091-3B7C-4EA0-A271-350E6D5E75C5 Q38770935-E985F14E-0E73-46EE-97EC-BBB19B9FC298 Q38793093-CE7FCC3A-12DF-4BCC-800D-3243E10EF4E0 Q39408199-CD4E6A10-580C-4B79-914F-8C2EA359E1CE Q39453553-376B30AC-8844-4237-80F4-D055420AF36A Q40149888-E90F8DC9-6B7D-427A-AEC8-BC70F517858B Q40444196-EA00AAC6-E40A-4D21-8508-0E9BB5D75341 Q40460053-27742D88-04C9-42D7-892F-4DA4764FFDFD Q40492081-6607376C-140E-4460-93DF-74F2503A1014 Q41505555-2DCA0A1E-D124-4AB1-928B-A535CC5FECAC Q41624551-473CF8EB-DAD9-4581-A918-E10210F26442 Q43763245-E6B18605-041C-43AC-A182-2A6D9B44740F Q47562193-26E59D42-BEEC-4C4D-801A-A1686BBC4B81 Q47813912-77388371-47F5-434D-9995-2BAB2D3EBD23 Q48138460-2EBDDF21-ADD6-422D-9F7D-54EEC859F9B9 Q48232396-0602F229-761A-43CB-871A-F4D3E1C49248 Q48499391-FECFBB12-6799-4F3D-A3CB-6A5D751BA164 Q49858111-1BE00102-62A2-4856-8159-0B8E61A2087B Q51736331-B145E7A1-EC9C-4727-B213-28BA61FA3D7E Q52595056-B0E96EE9-01C2-4AB8-A491-607092C306DF

P2860

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

http://www.wikidata.org/entity/Q41431886

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

@en

type

label

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

@en

prefLabel

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

@en

P1433

Q41431886-6FD5FAA2-275F-43B5-AC72-FEE4A61759AE

P1476

Q41431886-45A326A9-F7A5-404A-BB46-E956B74DEBE6

P2093

Q41431886-00328CD1-0114-44DE-9370-BC077167DBC6

Q41431886-05DD6A7C-7B2A-4BEC-8EC2-2ECC48C51F12

Q41431886-19F3FDC1-51D7-4EA2-A237-C55FABA9F615

Q41431886-1E545289-9D2C-4AC1-A5E2-FD114036D96F

Q41431886-1F32BDC7-0311-4876-9A41-35745A545173

Q41431886-246CC7A8-67DC-4A87-83D8-9DEF2C37335E

Q41431886-404FE5A4-088B-409F-90E8-C138230B22AC

Q41431886-4A1857AB-8188-4456-AA20-7ECDE429E55B

Q41431886-6A8C2C7D-A3C3-4925-8E62-1E748EBBB9F3

Q41431886-825BEF5D-55FC-4FA2-9F9B-3B27F19694DD

P2860

Q41431886-020EE968-FF36-482E-92CE-02C99D89A330

Q41431886-0F9CA33D-4B93-44D4-B09B-B2E974996739

Q41431886-1EA3E6DD-EB3B-4B0D-A5DD-0A43A7D57BD7

Q41431886-234743C3-CFE4-4D55-BEC1-AB00863784E0

Q41431886-32772209-DFB6-45FF-878E-807109573703

Q41431886-329C65EE-57FC-4585-9D15-179ECBDBD284

Q41431886-3C4D778A-2B4C-41AD-860D-1E0EC824BA13

Q41431886-40700178-C6A9-444A-A895-A23F61AB32FC

Q41431886-444FAA5B-90F7-4620-BA6C-C834C0DCA392

Q41431886-45592375-1AD8-432C-B170-4277868A9058

P304

Q41431886-5FD829DF-A965-4043-912F-465B19423078

P31

Q41431886-21D5958C-7E67-4018-A0BC-E1C0EC0559AA

P356

Q41431886-C7816796-1303-487A-BAFD-7A29186E303F

P433

Q41431886-28C532C1-01EF-46BF-B996-77EC46797863

P478

Q41431886-19FA0B08-424C-42B0-907E-E955526D5301

P50

Q41431886-D29558A2-2CE4-4118-A5D5-F3EE6CFC2090

P577

Q41431886-80A18CEB-5215-43E5-AB2B-9BDE46C57425

P698

Q41431886-3660EE57-C131-4E63-930F-E6D32984BCF5

P932

Q41431886-4BE26204-BF3C-42D4-90C9-3BD702665135

P356

2159-8290.CD-15-0274

P1433

Cancer Discovery

P1476

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas

@en

P2093

AmirAli Talasaz

http://www.w3.org/2001/XMLSchema#string

Andrew E Hendifar

http://www.w3.org/2001/XMLSchema#string

Andrew H Ko

http://www.w3.org/2001/XMLSchema#string

Chloe E Atreya

http://www.w3.org/2001/XMLSchema#string

Claire Greene

http://www.w3.org/2001/XMLSchema#string

Dragan Sebisanovic

http://www.w3.org/2001/XMLSchema#string

Eric A Collisson

http://www.w3.org/2001/XMLSchema#string

Katherine Van Loon

http://www.w3.org/2001/XMLSchema#string

Lai Mun Siew

http://www.w3.org/2001/XMLSchema#string

Margaret A Tempero

http://www.w3.org/2001/XMLSchema#string

P2860

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

Diagnostic tests. 1: Sensitivity and specificity

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

Age-related mutations associated with clonal hematopoietic expansion and malignancies

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

P304

1040-1048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2159-8290.CD-15-0274

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26109333

http://www.w3.org/2001/XMLSchema#string

P932

4592417

http://www.w3.org/2001/XMLSchema#string